Clinical trial
The Efficacy and Safety of Rhodiola Rosea in Patients With Coronary Microvascular Disease
NCT04218916 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Rhodiola Rosea in Patients With Coronary Microvascular Disease
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 31, 2020
- Completion date
- January 31, 2023
- Enrollment
- 114 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary microvascular disease